Ruth Bader Ginsburg Dies From Pancreatic Cancer Ruth Bader Ginsburg Dies From Pancreatic Cancer
The 87-year-old diminutive but fiery jurist was a three-time cancer survivor and became the second woman to serve on the US Supreme Court when President Bill Clinton appointed her in 1993.WebMD Health News (Source: Medscape Business of Medicine Headlines)
Source: Medscape Business of Medicine Headlines - September 19, 2020 Category: Pharmaceuticals Tags: Family Medicine/Primary Care News Alert Source Type: news

Ruth Bader Ginsburg Dies from Pancreatic Cancer
The three-time cancer survivor faced her most recent troubles in late 2018, when she had surgery for lung cancer that was discovered after she broke several ribs in a fall in her chambers. In January of 2020, Ginsburg announced that she was cancer free. But in July she said she was undergoing chemotherapy after a lesion was found on her liver. (Source: WebMD Health)
Source: WebMD Health - September 19, 2020 Category: Consumer Health News Source Type: news

How Cancer Shaped Justice Ruth Bader Ginsburg ’s Life and Work
The name Ruth Bader Ginsburg became almost synonymous with strength and stamina as she rose to prominence in judicial and feminist circles throughout her long career. Famously nicknamed the Notorious RBG and known for her grueling fitness regimen, the late Supreme Court justice also struggled with cancer and other health issues for the better part of her time on the bench — culminating with her death on Sept. 18 at the age of 87 of complications from metastatic pancreatic cancer. Ginsburg’s health issues became public in 1999, six years after her appointment to the Supreme Court, when she had surgery for early-...
Source: TIME: Health - September 19, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime remembrance Source Type: news

Supreme Court Justice Ruth Bader Ginsburg Dies at 87
FRIDAY, Sept. 18, 2020 -- U.S. Supreme Court Justice Ruth Bader Ginsburg died on Friday, the court announced. The cause was complications from pancreatic cancer. Ginsburg was 87. First appointed to the court in 1993 by President Bill Clinton,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 18, 2020 Category: General Medicine Source Type: news

Mayo Clinic and TGen ID potential targets for the most-deadly form of pancreatic cancer
(The Translational Genomics Research Institute) In what is believed to be the most comprehensive analysis of adenosquamous cancer of the pancreas (ASCP), the Mayo Clinic and TGen team identified, in preclinical models, therapeutic targets for this extremely fast-moving and deadly form of pancreatic cancer, and identified already available cancer inhibitors originally designed for other types of cancer, according to a study published today in the journal Cancer Research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2020 Category: International Medicine & Public Health Source Type: news

Pancreatic cancer symptoms: Have you smelt this when going to the toilet? Warning sign
PANCREATIC cancer survival outcomes depend on the stage of the cancer so it is imperative to act on the warning signs when they appear. One sign is associated with a particular smell - what is it? (Source: Daily Express - Health)
Source: Daily Express - Health - September 11, 2020 Category: Consumer Health News Source Type: news

Cancer Projects to Diversify Genetic Research Receive New Grants
Because much cancer research and clinical trials have been based on white populations, efforts to explore the ways race and ethnicity influence disease are underway. (Source: NYT Health)
Source: NYT Health - September 11, 2020 Category: Consumer Health News Authors: Emma Goldberg Tags: Race and Ethnicity Colon and Colorectal Cancer Pancreatic Cancer Bladder Cancer Breast Cancer Black People Genetics and Heredity Cold Spring Harbor Laboratory Dana-Farber Cancer Institute Memorial Sloan-Kettering Cancer Center Mount Si Source Type: news

New drug could improve life expectancy and quality for pancreatic cancer patients
(University of Sheffield) First-in-class drug starves certain tumor types of the resources they need to grow and spread to other parts of the body. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2020 Category: Cancer & Oncology Source Type: news

October 9, 2020: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM) Meeting Announcement - 10/09/2020 - 10/09/2020
October 9, 2020: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM) Meeting Announcement (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 2, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

How the COVID-19 Pandemic Has Changed Cancer Care, In 4 Charts
Before the pandemic, about 1,000 new patients came to Boston’s Dana-Farber Cancer Institute for treatment consultations each week. When COVID-19 hit Massachusetts this spring, the number of new consultations fell by half and the hospital moved as many appointments as possible online. Now, with daily case counts relatively low in the area, the hospital is back to scheduling about 800 consultations per week, using a mixture of telemedicine and in-person appointments, says associate chief medical officer Dr. Andrew Wagner—but that still means about 200 cancer patients per week are not getting the treatment consult...
Source: TIME: Health - August 28, 2020 Category: Consumer Health News Authors: Jamie Ducharme and Emily Barone Tags: Uncategorized COVID-19 Source Type: news

Pancreatic cancer: Mayo Clinic Radio Health Minute
In this Mayo Clinic Radio Health Minute, Dr. Mark Truty, a general surgeon at Mayo Clinic, discusses pancreatic cancer and explains the new treatment protocol that is offering hope. To listen, click the link below. Pancreatic cancer (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 26, 2020 Category: Databases & Libraries Source Type: news

Early Detection of Pancreatic Cancer Early Detection of Pancreatic Cancer
Detecting pancreatic cancer at its earliest stages remains challenging. What recent progress has been made in this area?Current Opinion in Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Diabetes, Weight Loss Increase Risk of Pancreatic Cancer Diabetes, Weight Loss Increase Risk of Pancreatic Cancer
A new study has linked recent-onset diabetes and subsequent weight loss to an increased risk of pancreatic cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 24, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Small change makes cancer vaccine more effective in animal tests
(Thomas Jefferson University) Tweaking the adenovirus spike protein induces a more robust immune reaction for a cancer vaccine against gastric, pancreatic, esophageal and colon malignancies in animal models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2020 Category: International Medicine & Public Health Source Type: news

Sortilin may hold the key to combat pancreatic cancer more effectively
(Elsevier) Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in The American Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 20, 2020 Category: International Medicine & Public Health Source Type: news

ASCO Updates Guideline for Metastatic Pancreatic Cancer ASCO Updates Guideline for Metastatic Pancreatic Cancer
Early testing for genomic alterations is now recommended for metastatic pancreatic cancer patients who progress on therapy or experience intolerable toxicity and who are candidates for additional treatment.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - August 19, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Recent Diabetes + Weight Loss Tied to Pancreatic Cancer Risk
Risk higher for those with recent - onset T2DM and weight loss of 1 to 8 pounds, more than 8 pounds (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 18, 2020 Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Gastroenterology, Internal Medicine, Oncology, Journal, Source Type: news

Recent Diabetes + Weight Loss Tied to Pancreatic Cancer Risk
TUESDAY, Aug. 18, 2020 -- Recent-onset diabetes accompanied by weight loss is associated with a substantially increased risk for developing pancreatic cancer, according to a study published online Aug. 13 in JAMA Oncology. Chen Yuan, Sc.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 18, 2020 Category: Pharmaceuticals Source Type: news

What Is the #1 Cause of Pancreatic Cancer?
Title: What Is the #1 Cause of Pancreatic Cancer?Category: Procedures and TestsCreated: 8/14/2020 12:00:00 AMLast Editorial Review: 8/14/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 14, 2020 Category: Cancer & Oncology Source Type: news

What Are the Early Warning Signs of Pancreatic Cancer?
Title: What Are the Early Warning Signs of Pancreatic Cancer?Category: Procedures and TestsCreated: 8/14/2020 12:00:00 AMLast Editorial Review: 8/14/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 14, 2020 Category: Cancer & Oncology Source Type: news

Diabetes increases risk for pancreatic cancer, study finds
Older adults with diabetes are nearly three times as likely to develop pancreatic cancer than the general population, according to an analysis published Thursday by JAMA Oncology. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 13, 2020 Category: Consumer Health News Source Type: news

Diabetes, weight change and pancreatic cancer risk
(JAMA Network) Researchers investigated an association between the duration of diabetes and recent weight loss with subsequent risk of pancreatic cancer in this observational study. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 13, 2020 Category: Cancer & Oncology Source Type: news

When to Screen BRCA Carriers for Colorectal, Pancreatic Cancer When to Screen BRCA Carriers for Colorectal, Pancreatic Cancer
New guidelines illuminate how these mutations can increase risk, but the final decision requires our own judgment, according to Dr David Johnson.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 12, 2020 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

COMBAT study preliminary results show response of 32% in treatment of pancreatic tumors
(The Translational Genomics Research Institute) Working with an international team of researchers, HonorHealth Research Institute and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, were instrumental in one of the first clinical trials showing how pancreatic cancer patients can benefit from immunotherapy, according to a four-year study published in a premier scientific journal, Nature Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 11, 2020 Category: Cancer & Oncology Source Type: news

Dr. Neville Sanjana receives 2020 Cancer Research Institute Technology Impact Award
(New York Genome Center) Neville Sanjana, Ph.D., Core Faculty Member at the New York Genome Center, Assistant Professor of Biology, New York University, and Assistant Professor of Neuroscience and Physiology, NYU School of Medicine, is the recipient of a 2020 Technology Impact Award from the Cancer Research Institute (CRI). Dr. Sanjana received this award to support his research study utilizing a new, high-throughput approach to overcome T-cell immunosuppression in pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 5, 2020 Category: Cancer & Oncology Source Type: news

Scientists discover novel drug target for pancreatic cancer
(Sanford Burnham Prebys Medical Discovery Institute) Scientists at Sanford Burnham Prebys Medical Discovery Institute have uncovered a novel drug target, a protein called PPP1R1B, that stops the deadly spread of pancreatic cancer, called metastasis, when inhibited in mice. Published in Gastroenterology, the findings are a first step toward a potential treatment for one of the deadliest cancers known today. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 5, 2020 Category: Cancer & Oncology Source Type: news

Scientists accelerate progress in preventing drug resistance in lung and pancreas cancers
(Huntsman Cancer Institute) Scientists at Huntsman Cancer Institute at the University of Utah report today the development of new models to study molecular characteristics of tumors of the lung and pancreas that are driven by mutations in a gene named NTRK1. The findings were published today in the journal Cell Reports. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2020 Category: International Medicine & Public Health Source Type: news

Doubts About Stroma-Targeting Agents in Pancreatic Cancer Doubts About Stroma-Targeting Agents in Pancreatic Cancer
Adding pegvorhyaluronidase alfa to treatment with nab-paclitaxel and gemcitabine did not improve survival in adults with previously untreated metastatic pancreatic ductal adenocarcinoma in a phase 3 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 3, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Rozlytrek, Roche ’s first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with ROS1-positive advanced non-small cell lung cancer
             Basel, 03 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has granted conditional marketing authorisation for Rozlytrek®(entrectinib) for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and who have not received a prior NTRK inhibitor, who have no satisfactory t...
Source: Roche Media News - August 3, 2020 Category: Pharmaceuticals Source Type: news

Rozlytrek, Roche ’s first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with ROS1-positive advanced non-small cell lung cancer
             Basel, 03 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has granted conditional marketing authorisation for Rozlytrek®(entrectinib) for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and who have not received a prior NTRK inhibitor, who have no satisfactory t...
Source: Roche Investor Update - August 3, 2020 Category: Pharmaceuticals Source Type: news

Ginsburg Hospitalized for Non-Surgical Procedure
It's been a tough month, health-wise, for Ginsburg. On July 17 she announced that she underwent chemotherapy to help fight a recurrence of pancreatic cancer, CNN reported. (Source: WebMD Health)
Source: WebMD Health - July 30, 2020 Category: Consumer Health News Source Type: news

Researchers Find a New Therapeutic Target in Pancreatic Cancer
A new study uncovers how the most commonly mutated tumor suppressor gene in cancer and the most commonly mutated oncogene in cancer cooperate to drive formation of pancreatic cancer. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - July 29, 2020 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release Research cancer research Norris Cotton Cancer Center Steven Leach Source Type: news

Stand Up To Cancer awards $1.1 million in grants to research teams
(Stand Up To Cancer) Stand Up To Cancer announced today five new awards that will cut across institutional and national lines to foster collaborative research and explore new paths to improve cancer treatment. The projects will receive a combined total of $1.1 million in funding to address some of the most pressing questions associated with colorectal, Ewing sarcoma, pancreatic, lung and pediatric cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 29, 2020 Category: International Medicine & Public Health Source Type: news

Mental Health: Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugs
The Psychopharmacologic Drug Advisory Committee (PDAC) is one of 33 advisory committees of the Food and Drug Administration (FDA). During committee meetings, an open public hearing takes place where speakers provide testimonies about the drug in question and are asked, not required, to disclose any conflicts of interests (COIs) before speaking. These speakers may present with COIs which include, but are not limited to, reimbursement for travel and lodging by the pharmaceutical company to attend the meeting; previous or current payments for consulting from the pharmaceutical company and compensation as a paid investigator i...
Source: Current Awareness Service for Health (CASH) - July 24, 2020 Category: Consumer Health News Source Type: news

The first mouse model of human pancreas cancer subtypes
(Cold Spring Harbor Laboratory) Organoids power the first mouse model of two pancreas cancer subtypes, identifying genes influencing a lethal transformation of one subtype to the other. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 23, 2020 Category: Cancer & Oncology Source Type: news

Mix and match: New 3D cell culture model replicates fibrotic elements of pancreatic cancer
(Okayama University) Pancreatic cancer is a deadly cancer characterized by prominent fibrosis, which plays a crucial role in disease progression and therapeutic resistance. Despite various efforts, experimental models to date have generally failed to fully recapitulate the extent of fibrosis in human tissue. Now, scientists at Okayama University, Japan, have reported a new method that uses a 3D cell culture technique to generate pancreatic cancer tissues in the laboratory with any given amount of fibrosis. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 22, 2020 Category: Biology Source Type: news

Ashion Analytics announces innovative cancer treatment partnership with Elevation Oncology
(The Translational Genomics Research Institute) Ashion Analytics today announced a partnership with Elevation Oncology, a clinical stage biopharmaceutical company, focused on the matching of patients with tumors harboring an NRG1 gene fusion identified using Ashion's proprietary GEM ExTra ® test with CRESTONE, a registration-directed Phase 2 study sponsored by Elevation Oncology. NRG1 gene fusions are a rare genomic alteration implicated as a driver of tumorigenesis and growth across many types of solid tumors, including lung, breast, pancreatic, ovarian, and colorectal cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2020 Category: Cancer & Oncology Source Type: news

Cinnamon May Slow Progression To Type 2 Diabetes, Boston Study Finds
(CNN) — Cinnamon may improve blood sugar control in people with a condition known as prediabetes and may slow the progression to type 2 diabetes, according to a new pilot study of 51 people with elevated blood sugars. “We are looking for safe, durable and cost-effective approaches to reduce the progression from prediabetes to type 2 diabetes,” said study author Dr. Giulio Romeo, a staff physician at Boston’s Joslin Diabetes Center and the division of endocrinology at Beth Israel Deaconess Medical Center. The study published Tuesday in the Journal of the Endocrine Society. “Our 12-week study sh...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 21, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Cinnamon CNN Diabetes Source Type: news

Civil Rights Icon and Congressman John Lewis Dies
Civil rights icon and congressman John Lewis, who had been diagnosed with pancreatic cancer last year, died at the age of 80. (Source: WebMD Health)
Source: WebMD Health - July 18, 2020 Category: Consumer Health News Source Type: news

Ruth Bader Ginsburg Says Cancer Has Returned, But Won't Hamper Her Work
FRIDAY, July 17, 2020 -- U.S. Supreme Court Justice Ruth Bader Ginsburg announced Friday that she is undergoing chemotherapy to help fight a recurrence of pancreatic cancer, CNN reported. The cancer has arisen once more, this time in her liver,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 17, 2020 Category: General Medicine Source Type: news

' Jeopardy' Host Alex Trebek Tells Fans Cancer Treatments Are'Paying Off '
FRIDAY, July 17, 2020 -- Fans of " Jeopardy " host Alex Trebek got a health update for the first time in months on Thursday when he told followers that his treatments for pancreatic cancer are " paying off. " " I'm doing well, " the 79-year-old host said... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 17, 2020 Category: General Medicine Source Type: news

Pancreatic cancer symptoms: The ‘smelly’ symptom that may signal you have it
PANCREATIC cancer symptoms usually do not emerge until the cancer has progressed. When symptoms do appear, they can be vague and non-specific, such as experiencing an unpleasant smell. (Source: Daily Express - Health)
Source: Daily Express - Health - July 15, 2020 Category: Consumer Health News Source Type: news

Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
             Basel, 14 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Blueprint Medicines Corporation (NASDAQ:BPMC), today announced the signing of a licensing and collaboration agreement providing exclusive rights to Roche for global co-development and commercialisation outside the United States (US), excluding Greater China*. In the US, Genentech, a member of the Roche Group, will obtain co-commercialisation rights to pralsetinib, Blueprint Medicine ’s investigational, once-daily oral precision therapy for the treatment of people with RET-altered ...
Source: Roche Media News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Pancreatic cancer symptoms: The sign in your stomach that could signal the deadly disease
PANCREATIC cancer - almost seven out of 10 people with this disease go to their doctor with the same symptom, according to the charity Cancer Research UK. Which symptom could it be? (Source: Daily Express - Health)
Source: Daily Express - Health - July 12, 2020 Category: Consumer Health News Source Type: news

Pancreatic cancer symptoms: Seek help if your urine turns this colour
PANCREATIC cancer is harder to treat in the later stages so it is important to act on the warning signs as soon as they appear. One warning can be seen in the colour of your urine. (Source: Daily Express - Health)
Source: Daily Express - Health - July 9, 2020 Category: Consumer Health News Source Type: news

Breakthrough with cancer vaccine
(Translational Research Institute) Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 9, 2020 Category: Cancer & Oncology Source Type: news

NCI Studying New Mesothelioma Immunotherapy Combination
Patients with mesothelioma are being recruited by the National Cancer Institute for a phase II clinical trial using a novel immunotoxin prior to pembrolizumab, a combination that has shown preliminary evidence of efficacy. This promising mesothelioma clinical trial involves the drug LMB-100, designed to make immunotherapy agents such as pembrolizumab, otherwise known as Keytruda, more effective. NCI’s trial includes separate cohorts for pleural and peritoneal types of mesothelioma. “This is a very good option for these patients,” medical oncologist Dr. Raffit Hassan, an acclaimed investigator at the Natio...
Source: Asbestos and Mesothelioma News - July 8, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Early clinical trial tests treatment strategy for pancreatic cancer
(Wiley) Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 8, 2020 Category: Cancer & Oncology Source Type: news

Blocking cholesterol storage could stop growth of pancreatic tumors
(Cold Spring Harbor Laboratory) Scientists at Cold Spring Harbor Laboratory found they can stop the growth of pancreatic cancer cells by interfering with the way the cells store cholesterol. Their findings in mice and lab-grown pancreas models point toward a new strategy for treating deadly pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Inflammatory Bowel Disease and Pancreatic Cancer Inflammatory Bowel Disease and Pancreatic Cancer
Do patients with IBD have a significantly increased risk of pancreatic cancer?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news